New ‘Emergency’ Market Beckons For Spravato Depression Spray

 
• By Neena Brizmohun

The therapeutic indication of Spravato is set to be expanded in the EU after receiving the thumbs up from the European Medicines Agency. The nasal spray has been shown to reduce depressive symptoms in just four hours and would fill a key unmet need, says the drug’s developer, Janssen.

depressed Women sitting head in hands on the bed in the dark bedroom with low light environment, dramatic concept
Janssen's Spravato spray may soon be availlable for psychiatric emergency cases • Source: Shutterstock

More from Europe

More from Geography